All Pharma News
price-trendAsk Us
HotSpot Presents Data for Potential First-in-Class MALT1 Scaffolding Inhibitor

HotSpot Presents Data for Potential First-in-Class MALT1 Scaffolding Inhibitor
PR NEWSWIRE
11 Dec 2023
Share Share
HotSpot Therapeutics to Introduce First-in-Class MALT1 Scaffolding Inhibitor

HotSpot Therapeutics to Introduce First-in-Class MALT1 Scaffolding Inhibitor
PR NEWSWIRE
02 Nov 2023
Share Share
HotSpot Therapeutics Achieves First-In-Human Dosing with HST-1011

HotSpot Therapeutics Achieves First-In-Human Dosing with HST-1011
PR NEWSWIRE
11 Apr 2023
Share Share
US FDA clears HotSpot Therapeutics’ IND application for HST-1011

US FDA clears HotSpot Therapeutics’ IND application for HST-1011
PHARMABIZ
03 Jan 2023
Share Share
AbbVie connects with HotSpot for $40M cash

AbbVie connects with HotSpot for $40M cash
Gabrielle Masson FIERCEBIOTECH
06 Dec 2022
Share Share
Excelra Partners with HotSpot to Enhance Allosteric Drug Discovery Efforts

Excelra Partners with HotSpot to Enhance Allosteric Drug Discovery Efforts
PRNEWSWIRE
25 May 2022
Share Share
HotSpot Tx Presents Pre-Clinical Data on CBL-B Program at AACR

HotSpot Tx Presents Pre-Clinical Data on CBL-B Program at AACR
PRNEWSWIRE
08 Apr 2022
Share Share
Caris, HotSpot collaborate to advance precision medicine development

Caris, HotSpot collaborate to advance precision medicine development
PHARMABIZ
11 Jan 2022
Share Share
HotSpot gets hotter with $100M raise to push toward clinic

HotSpot gets hotter with $100M raise to push toward clinic
Paul Schloesser ENDPTS
29 Nov 2021
Share Share